What’s being presented at ASCO this year: II

A “first-of-its kind” quality of life study to be presented at ASCO this year is a year-long, randomized, three-arm trial of the value of “purposeful” physical exercise in the management of men on androgen deprivation therapy (ADT) for progressive prostate cancer. … READ MORE …

Strength training and quality of life in Black prostate cancer patients on ADT

Black males have high rates of incidence and mortality associated with prostate cancer … significantly higher than Caucasians of similar ages. Thus, Black male patients are more likely to require androgen deprivation therapy (ADT) for prostate cancer (PCa), and suffer associated side effects (including loss of muscle mass, weakness, fatigue, and reduced quality of life [QoL]). … READ MORE …

Thursday’s prostate cancer news: October 23, 2008

In addition to publication of the cryotherapy best practice guidance, other news today includes:

  • Information about selenium levels in blood and prostate tissues
  • An hypothesis about sex steroid-induced inflammatory events as a trigger for prostate cancer development
  • The role of free PSA in diagnosis of prostate cancer in men with a total PSA ≤ 2.5 ng/ml
  • The impact of hormone therapy on strength and musculoskeletal performance … READ MORE …